Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)

Authors:

Abstract
No abstract available
Funding Information
  • Actelion Pharmaceuticals

This publication has 24 references indexed in Scilit: